The beauty divisions of Givaudan, dsm-firmenich, IFF and Symrise delivered an estimated weighted average organic growth of around 9% in Q3 2026, up from 6.7% in Q2. Givaudan, dsm-firmenich and Symrise accelerated, while growth moderated at IFF. Fragrance remained an important growth engine across the industry.

Givaudan’s Fragrance & Beauty sales reached €1,231m in Q3, up 13.5% like-for-like, compared with 7.1% in Q2. Over the first nine months, Fine Fragrance grew 15.3% and Consumer Products 9.3%, while Fragrance Ingredients and Active Beauty continued to decline.
At dsm-firmenich, Perfumery & Beauty grew 8% like-for-like to €1,015m in Q3, compared with 7% in Q2. Growth was driven by volume, with Consumer Fragrances up double digits and Fine Fragrances growing high single digits. Ingredients also improved, growing mid-single digits.
IFF’s Scent sales rose 6% at constant rates to €627m in Q3, compared with 7.8% growth in Q2. Consumer Fragrances led the increase, while Fine Fragrance and Fragrance Ingredients both grew mid-single digits.
Symrise’s Scent & Care division accelerated from 3.8% organic growth in Q2 to 5.6% in Q3, reaching €520m. Consumer Fragrance and Aroma Molecules grew high single digits, while Care & Wellness returned to growth despite a continued double-digit decline in UV Filters.
Takasago’s Fragrance sales reached an estimated €131m in calendar Q3, up approximately 24.5% on a reported basis, compared with 22.2% in Q2. Its first-half performance was supported by Fabric Care in Southeast Asia and China and Fine Fragrances in Europe.
Subscribe to my newsletter for weekly insights on the beauty industry. Link below.